Erectile Dysfunction Meds Tied to Higher Risk for Vision Issues - HealthDay News
4/11/2022 12:00:00 AM3 yearsago
by Physician’s Briefing Staff
by Physician’s Briefing Staff
Regular users may be at risk for serous retinal detachment, retinal vascular occlusion, and ischemic optic neuropathy
MONDAY, April 11, 2022 (HealthDay News) -- Regular users of phosphodiesterase type 5 inhibitors (PDE5Is) for erectile dysfunction may have an increased risk for adverse ocular events, according to a … [+1478 chars]
full article...